Stock Events

Stock Events

Kalaris Therapeutics (KLRS) Q1 2026 Earnings

17MarConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-2.52

-1.83

-1.15

-0.46

Details

Expected EPS

-0.586

Actual EPS

-0.534652

Surprise EPS

0.05

Surprise Percent

+8.76%

Description

Kalaris Therapeutics (KLRS) has reported earnings of -0.534652 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.